Company announcementno 2024-01 |
Transactions with Demant shares by managers and
closely related parties
Notification pursuant to article 19 of the Market Abuse Regulation.
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | Søren Nielsen | |
2. | Reason for the notification | |
a) | Position/status | President & CEO |
b) | Initial notification/amendment | Initial notification |
3) | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | ||
b) | LEI | 213800RM6L9LN78BVA56 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0060738599 |
b) | Nature of the transaction | Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2023. |
c) | Price(s) and volume(s) | Price(s) Volume(s)
Allocated shares in Q1:
The share price corresponds to the average share price quoted on Nasdaq Copenhagen in week 4 of 2023.
Allocated shares from April until December:
The share price corresponds to share price of the 8th trading dayfollowing the conclusion of the respective month. |
d) | Aggregated information: - Aggregated volume - Price |
Aggregated volume: 4,946 shares
Price: |
e) | Date of the transaction | |
f) | Place of the transaction |
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | ||
2. | Reason for the notification | |
a) | Position/status | CFO |
b) | Initial notification/amendment | Initial notification |
3) | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | ||
b) | LEI | 213800RM6L9LN78BVA56 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0060738599 |
b) | Nature of the transaction | Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2023. |
c) | Price(s) and volume(s) | Price(s) Volume(s)
Allocated shares in Q1:
The share price corresponds to the average share price quoted on Nasdaq Copenhagen in week 4 of 2023.
Allocated shares from April until December:
The share price corresponds to share price of the 8th trading dayfollowing the conclusion of the respective month. |
d) | Aggregated information: - Aggregated volume - Price |
Aggregated volume: 3,577 shares
Price: |
e) | Date of the transaction | |
f) | Place of the transaction |
1. | Details of the person discharging managerial responsibilities/person closely associated | |
a) | ||
2. | Reason for the notification | |
a) | Position/status | President of Hearing Care Member of the Executive Board |
b) | Initial notification/amendment | Initial notification |
3) | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a) | ||
b) | LEI | 213800RM6L9LN78BVA56 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a) | Description of the financial instrument, type of instrument
Identification code | Shares
DK0060738599 |
b) | Nature of the transaction | Purchase of shares under share salary arrangement in accordance with section 7p of the Danish Tax Assessment Act, i.e. voluntary conversion of part of the remuneration into shares. Sign-up for participation in the arrangement was done at the beginning of 2023. |
c) | Price(s) and volume(s) | Price(s) Volume(s)
Allocated shares in Q1:
The share price corresponds to the average share price quoted on Nasdaq Copenhagen in week 4 of 2023.
Allocated shares from April until December:
The share price corresponds to share price of the 8th trading dayfollowing the conclusion of the respective month. |
d) | Aggregated information: - Aggregated volume - Price |
Aggregated volume: 2.870 shares
Price: |
e) | Date of the transaction | |
f) | Place of the transaction |
Further information: Peter Pudselykke, Investor Relations Officer
Phone +45 3917 7300 www.demant.com |
Contacts
Henrik Axel Lynge Buchter , External Communication Manager, Corporate Communication & Sustainability, +45 2264 9982, heey@demant.com
About Demant A/S
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people’s health and hear-ing. We create life-changing differences through hearing health.
Attachments
- 2024-01 Managers and closely related parties transactions with Demant shares.pdf
© Ritzau Denmark, source